Valneva SE ADR (VALN)
Alto Neuroscience Inc. (ANRO)
Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Alto Neuroscience, Inc. (NYSE: ANRO) between Feb. and Oct. 2024 should contact the Shareholders Foundation
Genprex Inc. (GNPX)
Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers
Biodexa Pharmaceuticals PLC (BDRX)
Genprex Inc. (GNPX)
Biodexa Pharmaceuticals PLC (BDRX)
Co-Diagnostics Inc (CODX)
Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.
Biodexa Pharmaceuticals PLC (BDRX)
Merit Medical Systems Inc (MMSI)
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
Y-mAbs Therapeutics Inc (YMAB)
PharmaCyte Biotech Inc. (PMCB)
New Form 8-K - PharmaCyte Biotech, Inc. Filed: 2025-08-18 AccNo: 0001683168-25-006274 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
PharmaCyte Biotech Inc. (PMCB)
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
Autonomix Medical Inc. (AMIX)
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
SpringWorks Therapeutics (SWTX)
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors